Multiple Myeloma Clinical Trial Benefits

March 11, 2020/in Cancer, Cancer Clinical Trial, Clinical Trial, Clinical Trial Success, NIH

Multiple Myeloma is a type of blood cancer that starts in white blood cells called plasma cells, which help your body fight infections. Mutations occur when the genetic material in plasma cells changes, causing plasma cells to become problematic myeloma cells. As myeloma cells multiply, they crowd out normal blood cells inside bone marrow, and that’s when symptoms can appear.

In this video from the National Institutes of Health (NIH), Pamela shares her reasons for choosing to participate in a clinical trial to help treat her stage 3B multiple myeloma. Find more information about clinical trials in your community here.